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Introduction
The scheduled separation of chromosomes is crucial for bal-
anced chromosome segregation. A cohesin complex keeps sister 
chromatids held together until the onset of anaphase (Nasmyth, 
2002;  Yanagida, 2005). If centromeric cohesion is impaired, sister   
chromatids  separate  before  anaphase,  resulting  in  premature 
chromatid separation (PCS; Kitajima et al., 2006; Toyoda and 
Yanagida, 2006). We previously reported that PCS occurs in 
the peripheral blood lymphocytes (PBLs) of HIV-1–infected 
individuals (Shimura et al., 2005). Strikingly, in vitro HIV-1 
infection induced PCS in PBLs isolated from healthy humans, 
strongly suggesting that a viral factor was responsible for PCS. 
As PCS has been associated with aneuploidy, it is important to 
identify the mechanisms involved (Thompson et al., 1993; Zhu 
et al., 1995; Kajii et al., 2001).
Centromere cohesion is regulated by a cohesin com-
plex, which consists of four evolutionarily conserved sub-
units:  the  structural  maintenance  of  chromosome  (SMC) 
proteins Smc1 and Smc3 and the non-SMC proteins Scc3/
SA and Scc1/Rad21/kleisin (Hirano, 2005). During mitosis, 
cohesin complexes at the chromosome arm are released non-
proteolytically in a process mediated by Aurora B (AurB) 
and Pololike kinase 1 (Losada et al., 2002; Sumara et al., 
2002; Giménez-Abián et al., 2004). In contrast, centromeric 
A
lthough  pericentromeric  heterochromatin  is  es-
sential for chromosome segregation, its role in 
humans  remains  controversial.  Dissecting  the 
function of HIV-1–encoded Vpr, we unraveled important 
properties of heterochromatin during chromosome segre-
gation. In Vpr-expressing cells, hRad21, hSgo1, and 
hMis12, which are crucial for proper chromosome segre-
gation, were displaced from the centromeres of mitotic 
chromosomes, resulting in premature chromatid separa-
tion (PCS). Interestingly, Vpr displaced heterochromatin 
protein 1- (HP1-) and HP1- from chromatin. RNA inter-
ference (RNAi) experiments revealed that down-regulation 
of HP1- and/or HP1- induced PCS, concomitant with 
the displacement of hRad21. Notably, Vpr stimulated the 
acetylation of histone H3, whereas p300 RNAi attenuated 
the Vpr-induced displacement of HP1- and PCS. Further-
more, Vpr bound to p300 that was present in insoluble 
regions of the nucleus, suggesting that Vpr aberrantly re-
cruits  the  histone  acetyltransferase  activity  of  p300  to 
chromatin, displaces HP1-, and causes chromatid cohe-
sion defects. Our study reveals for the first time centro-
mere  cohesion  impairment  resulting  from  epigenetic 
disruption of higher-order structures of heterochromatin 
by a viral pathogen.
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Results
Vpr is responsible for PCS caused  
by HIV-1
To identify the HIV-1 gene responsible for PCS, we infected 
human  PBLs  with  wild-type  (wt)  or  mutant  viruses  (vpu, 
vpr,  and  vif;  Fig.  1  A,  bottom).  HIV-1  consists  of  nine 
ORFs containing three structural genes, gag, pol, and env, plus 
the regulatory genes rev and tat, together with four different 
accessory genes, vif, vpr, vpu, and nef (Fig. 1 A, top). In this 
study, we used vesicular stomatitis virus glycoprotein (VSV-G)–
pseudotyped viruses lacking the nef gene to perform a single-
round replication assay (Kinomoto et al., 2007) in which we 
introduced mutations only into accessory genes with no influ-
ence on the rate of infection (Malim and Emerman, 2008). As 
shown in Fig. 1 B, PCS was observed in cells infected with wt, 
vpu, and vif viruses but not by vpr virus (Fig. 1 C, left). 
We carefully examined >300 chromosome spreads in each ex-
periment. A chromosome spread was considered PCS positive 
if more than three chromosomes lacked linkages between sis-
ter chromatids. We obtained similar results in two additional 
independent experiments (Fig. S1 A). Infection rates with a 
multiplicity of infection of 0.007 were comparable, as assessed 
by luciferase reporter activity (Fig. 1 C, right), suggesting that   
vpr is responsible for HIV-1–associated PCS. Next, we exam-
ined PCS in MIT-23 cells, which stably express Vpr under the   
control of a tetracycline-inducible promoter (Shimura et al., 
1999). On day 2 after the addition of doxycycline (DOX), PCS 
was clearly detected in >40% of treated cells (Fig. 1 D, right) 
but not in control cells (Fig. 1 D, left). To characterize the   
dosage of Vpr in MIT-23 cells, its expression was compared with 
HIV-1–infected  cells.  The  level  of  Vpr  in  DOX-treated   
MIT-23 cells was less than one seventh of that in virus-producing   
U1 cells, which are latently infected and carry two copies of 
provirus HIV-1 DNA (Fig. S1, B and C; Folks et al., 1987). 
Based on these data, we conclude that Vpr is responsible for 
the PCS induced by HIV-1 infection.
Consistent with studies linking PCS with aberrant segre-
gation of sister chromatids (Babu et al., 2003; Sotillo et al., 
2007;  Zhang  et  al.,  2008),  numerous  Vpr-expressing  G2/M 
phase cells displayed altered ploidy (Fig. 1 E). Time-lapse   
analysis revealed that mitosis was prolonged in Vpr-expressing 
cells (Fig. S1 D, right). Furthermore, >50% of the mitotic Vpr-
expressing cells examined displayed abnormal mitosis (Fig. S1 D 
and Videos 1–3). Interestingly, Vpr-expressing cells suffered 
no apparent cellular crisis, as judged by FACS analysis of the 
sub-G1 population (Fig. 1 E) and increased aneuploidy (Fig. 1 E, 
arrow), which is consistent with our previous finding (Shimura 
et al., 1999).
Vpr causes cohesion defects primarily  
in mitosis
Because chromosome segregation is tightly controlled by cen-
tromeric cohesin (Nonaka et al., 2002; Pidoux and Allshire, 
2004), we first investigated the expression of the cohesin subunits 
Smc1, Smc3, and Scc1/Rad21 in Vpr-expressing MIT-23 cells.   
2 d after the induction of Vpr expression, the chromatin-enriched 
cohesin is protected until the onset of anaphase by Shugosin 
(hSgo1;  Kitajima  et  al.,  2006).  Importantly,  previous  ob-
servations suggested that cohesion is functionally linked to 
heterochromatin structure. For example, the degradation of 
Drosophila melanogaster heterochromatin protein 1 (HP1), 
which functions as a component of silent heterochromatin, 
causes  unbalanced  chromosome  segregation  (Kellum  and 
Alberts, 1995). In fission yeast, Swi6, a homologue of HP1, 
is important for maintaining Scc1/Rad21 at the centromere 
until anaphase (Nonaka et al., 2002; Pidoux and Allshire, 
2004). In humans, however, there is controversy regarding 
the  regulation  of  centromeric  cohesin  complexes  during  mi-
tosis by HP1, which exists as three subtypes: HP1-, HP1-, 
and HP1-. Inoue et al. (2008) reported that the dominant-
negative form of HP1- is involved in centromere cohesion. 
Previously,  we  showed  that  HP1-  RNAi  induced  hSgo1   
mislocation,  suggesting  that  HP1-  RNAi  induced  PCS 
(Yamagishi et al., 2008). In contrast, Mateos-Langerak et al. 
(2007)  reported  that  no  HP1  dominant-negative  mutants 
showed  detectable  effects  on  the  centromeric  heterochro-
matin. Recently, Serrano et al. (2009) suggested that none of 
the three HP1 subtypes has a definite role in the loading of 
cohesion to chromatin.
Here, we found that vpr, an HIV-1 accessory gene, was 
responsible for HIV-1–associated PCS. The vpr gene encodes 
Vpr, a virion-associated nuclear protein (Cohen et al., 1990) 
that binds p300 and facilitates transcription from HIV-1 pro-
moters (Felzien et al., 1998; Kino et al., 2002). Strikingly, we 
observed that Vpr reduced the levels of chromatin-associated 
HP1- and HP1- and concomitantly triggered the displace-
ment of hRad21, hSgo1, and an HP1-/-–interacting protein, 
hMis12,  all  of  which  are  critically  involved  in  centromere 
cohesion and kinetochore functions (Goshima et al., 2003; 
Obuse et al., 2004). To investigate the molecular mechanisms   
underpinning  Vpr-induced  PCS,  we  examined  the  effects 
of HP1 RNAi and found that the down-regulation of HP1-
 and/or HP1- induced PCS, coinciding with the displace-
ment of hRad21 from centromeres. Additional experiments 
using  p300/histone  acetyltransferase  (HAT)  inhibitors  and 
RNAi-based assays revealed that Vpr-induced PCS and the 
displacement of HP1- from chromatin depended on the HAT 
activity of p300. Based on these data, we conclude that Vpr 
aberrantly  modulates  p300/HAT  activity  and  induces  PCS   
by causing defects in the higher-order structures of centro-
meric heterochromatin.
High rates of PCS have been reported in human diseases 
caused by mutations in genes essential for chromatid cohesion, 
including ESCO2 and NIPBL/Adherin, which are responsible 
for Roberts syndrome and Cornelia de Lange syndrome, re-
spectively (Kaur et al., 2005; Vega et al., 2005; Dorsett, 2007), 
and are involved in the spindle assembly checkpoint, including 
Bub1 (Kajii et al., 2001). PCS is also observed in malignant 
cancers (Thompson et al., 1993; Zhu et al., 1995). Although 
the  molecular  mechanisms  behind  these  pathological  condi-
tions remain unclear, our data indicate that centromere proteins 
are  susceptible  to  disruption  by  the  epigenetic  modification   
of chromatin.723 HP1 in mitotic centromere cohesion • Shimura et al.
Figure 1.  Vpr mediates HIV-1–induced PCS. (A) A schematic structure of 
HIV­1 pNL43 (original clone) and pNL­LUC­E
 (env/wt). wt and mutant 
viruses were env deficient (env), and nef was replaced by the luciferase 
(Luc) gene. The accessory genes vif, vpr, and vpu were mutated (yield­
ing vif, vpr, and vpu, respectively). (B) Representative chromosome 
spreads from PBLs infected or not infected with wt or mutant virus (vpr, 
vpu, or vif). PBLs were synchronized with colcemid. Cont, control. Bar, 
10 µm. (C) A luciferase assay was used to determine the virus produc­
tion rate (right) and PCS frequency (left). (D) Chromosome spreads were   
Giemsa stained. At 48 h, the frequency of PCS was >40% in DOX­induced 
Vpr­transfected cells (far right) and <3% in nontreated cells (middle right). 
In contrast, mock­transfected cells (Vpr) showed no difference in PCS fre­
quency with or without DOX treatment (<3%; left). Bar, 5 µm. (E) The cell 
cycle was analyzed using FACS after DOX addition (days 0–5). Vpr (left) 
and MIT­23 (right) cells are shown. Arrow, hyperploidy/aneuploidy. All 
data are representative of at least three independent experiments.
insoluble fraction was isolated using a reported method (Todorov 
et al., 1995), and protein expression was assayed by immuno-
blotting. The amount of Smc1, Smc3, and Scc1/hRad21 proteins 
in the isolated chromatin decreased by 79, 58, and 53%, respec-
tively (Fig. 2 A, top). In striking contrast, the levels of these 
proteins in whole-cell extracts remained stable (Fig. 2 A,   
bottom), suggesting that Vpr altered their subcellular localiza-
tion.  To  focus  on  cohesin  localizing  to  condensed  chromo-
somes, we prepared chromosome spreads from Vpr-expressing 
cells and stained them with an antibody against hRad21 (Hoque 
and Ishikawa, 2002). As shown in Fig. 2 B, only small amounts 
of hRad21 were observed in the spreads, in which sister chro-
matids were aligned loosely as a result of PCS (Fig. 2 B, right). 
In contrast, intense hRad21 signals were detected in control 
cells, especially at the interface of sister chromatids within the 
centromere, as has been previously described (Fig. 2 B, left; 
Waizenegger et al., 2000).
Next, to study the effects of Vpr expression on the chro-
matin localization of hRad21 in interphase, MIT-23 cells were 
immunostained for chromatin-bound hRad21, and hRad21 in-
tensities and the nuclear sizes were analyzed (Fig. S2, A and B). 
Chromatin-associated hRad21 levels were not reduced in regu-
larly sized Vpr-expressing cells during interphase, though they 
were greatly reduced in mitotic cells (Fig. S2 A). Interestingly, 
the  cells  with  larger  nuclei  had  statistically  less  chromatin-
bound hRad21 (Fisher’s exact test, P = 0.002; Fig. S2 B, bottom). 
As this population of cells could be produced via defective 
chromosome segregation (Figs. 1 E and S1 D), the results sug-
gested that the diminished association of hRad21 to the inter-
phase  chromatin  was  observed  after  hRad21  mislocalization   
at mitosis.
Cohesin loading onto the interphase chromatin depends 
on NIPBL/delangin in human cells (Toyoda and Yanagida, 
2006).  This  encouraged  us  to  examine  the  involvement  of 
NIPBL/delangin in the Vpr-induced PCS. RNAi depletion of 
NIPBL caused specific down-regulation of delangin/NIPBL 
(Fig. S2 C). The introduction of NIPBL RNAi decreased the 
hRad21 signal during interphase remarkably (Fig. S2 C, bot-
tom  right),  whereas  chromatin-associated  hRad21  was  ob-
served in control cells (Fig. S2 C, bottom left). Transfection of 
MIT-23 cells with NIPBL RNAi did not alter the frequency of 
PCS (Fig. S2 D). In contrast, and in line with a previous study 
(Kaur et al., 2005), it induced PCS in 8.3% of control cells 
(Fig. S2 D). These data suggest that NIPBL is not a primary 
Vpr target and that Vpr-induced PCS results from cohesin de-
fects that first become apparent in mitosis. Therefore, we then 
focused on the mitotic phenotypes to clarify the mechanisms 
underlying Vpr-induced PCS.
Vpr causes failure in protecting cohesin  
on the mitotic chromatin
Next,  we  addressed  whether  Vpr-induced  mislocalization  of 
hRad21 was a result of the displacement of the guardian protein 
hSgo1 from the mitotic centromere chromatin. MIT-23 cells 
and their chromosome spreads were immunostained for hSgo1 
(Fig. 2 C). Upon Vpr expression, hSgo1 was undetectable on 
spread chromosomes and prometaphase cells (Fig. 2 C, bottom JCB • VOLUME 194 • NUMBER 5 • 2011   724
Vpr expression displaces HP1 and hMis12 
from chromatin
In fission yeast, Swi6, an HP1 homologue, functions as a key 
regulator  of  centromere  cohesion  during  mitosis  (Nonaka   
et al., 2002; Pidoux and Allshire, 2004). HP1- also regulates 
the localization of hSgo1 (Yamagishi et al., 2008). Therefore, 
we analyzed HP1 in Vpr-expressing cells. Western blot analysis 
using antibodies against three subtypes of human HP1 (HP1-, 
HP1-, and HP1; Hayakawa et al., 2003) revealed that Vpr de-
creased the amounts of HP1- and HP1- in the isolated chro-
matin (see Materials and methods; Remboutsika et al., 1999) 
by >90 and 20%, respectively (Fig. 3 A). Comparable results 
were obtained upon immunostaining chromatin-bound HP1- 
right and middle), but prophase cells exhibited centromere local-
ization of hSgo1 (Fig. 2 C, bottom left). As AurB and inner 
centromere protein (INCENP), which form a protein complex 
chromosomal passenger complex (CPC; Adams et al., 2001), 
regulate hSgo1 localization (Kawashima et al., 2007; Pouwels 
et al., 2007), their localization was assessed on Vpr expression 
(Fig. 2, D and E). AurB and INCENP targeting to the inner cen-
tromere was reduced significantly in Vpr-expressing prometa-
phase  cells  but  not  in  prophase,  whereas  the  centromere 
localization of CENP-A and CENP-H proteins was not affected 
(P < 0.01; Fig. 2, D and E). These data indicate that Vpr causes 
failure in the protection of cohesin in mitosis, which becomes 
apparent after prophase.
Figure 2.  Altered localization of cohesin and 
its regulators in Vpr-expressing cells. (A) Ex­
pression of the cohesin proteins Smc1, Smc3, 
and  hRad21  in  DOX­treated  MIT­23  versus 
Vpr  cells  at  48  h.  Ch,  isolated  chromatin; 
Wh,  whole­cell  lysate.  Loading  controls:  his­
tone H3 (HH3) and ­tubulin (Tub). Data are 
representative  of  at  least  three  independent 
experiments. (B) Anti­hRad21 staining in DOX­
treated MIT­23 cells versus Vpr cells. Arrows 
indicate  hRad21  signals  at  the  interface  of 
sister chromatids within the centromere, and 
arrowheads  indicate  undetectable  hRad21 
signals  at  loosely  aligned  sister  chromatids. 
Blue, DNA; red, hRad21. Similar results were 
obtained  in  three  independent  experiments. 
(C)  Anti­hSgo1  immunostaining.  (D  and  E, 
top) Immunostaining of AurB (D) or INCENP 
(E) in early mitosis. (insets) Magnifications of 
the centromere. (bottom) Intensities of AurB (D) 
or INCENP (E) at the inner centromere region.   
*, P < 0.0001 (AurB) and P = 0.0002 (INCENP) 
versus Vpr­expressing cells in prophase. Val­
ues  represent  the  mean  ±  SD.  (C–E)  Results 
are representative of three independent experi­
ments. Bars: (B and C [right]) 5 µm; (C [middle], 
D, and E) 10 µm; (D and E, insets) 0.5 µm.725 HP1 in mitotic centromere cohesion • Shimura et al.
Figure 3.  Altered localization of HP1-, HP1-, and hMis12 proteins in Vpr-expressing cells. (A) HP1­, HP1­, and HP1­ expression in DOX­treated 
MIT­23 and Vpr cells. Loading control (Cont): a major band of the chromosomal fraction corresponding to 15 kD by Coomassie brilliant blue staining. 
(B) Chronological changes in HP1­ and hRad21 in the chromosomal (Ch) versus whole­cell (Wh) fractions after DOX addition (days 0–3). Tub, ­tubulin; 
Vpr, Vpr expression. Data are representative of three independent experiments. (C) Cells were preextracted with PBS containing Triton X­100 and stained 
with anti–HP1­ antibody and Hoechst 33342. In the bottom right, the pictured cells are in interphase (top cell) and undergoing mitosis (bottom cell). Similar 
results were obtained in at least three independent experiments. (D) Chromosome spreads were immunostained for HP1 subtypes and CENP­H. Similar 
results were obtained in three independent experiments. (E) Mitotic cells were immunostained for hMis12 and CENP­A. (F) Chromosome spreads prepared 
from DOX­induced cells (48 h) were immunostained for hMis12 and CENP­A. (G, left) DOX­induced cells (48 h) were immunostained for hMis12 and 
CENP­A. (insets) Magnifications of the centromere. (right) The hMis12/CENP­A signal intensity ratio was measured during prophase and prometaphase. 
Gray bars, Vpr cells; black bars, MIT­23 cells. Values represent the mean ± SD (three experiments) of data generated using the cells shown on the left.   
*, P = 0.0008 versus Vpr­expressing cells in prophase. (H) Chromosome spreads immunostained with CENP­A and CENP­H antibodies and ACA antisera. 
Blue, DNA; red, CENP­A, ACA, or CENP­H. Vpr (), DOX­treated Vpr cells at 48 h; Vpr (+), DOX­treated MIT­23 cells at 48 h. Bars: (C, E, and G) 10 µm;   
(D, F, and H) 5 µm; (G, insets) 0.5 µm.JCB • VOLUME 194 • NUMBER 5 • 2011   726
sister kinetochores at prophase and prometaphase (see Mate-
rials and methods). In Vpr-expressing cells, the hMis12/CENP-A   
signal ratio was decreased significantly when cells entered pro-
metaphase (P < 0.01; Fig. 3 G, black bar), whereas in control 
cells, it was comparable to that measured at prophase (Fig. 3 G,   
gray bar). These results suggest that Vpr interferes with the 
heterochromatin structure by displacing HP1-/- proteins in 
interphase and that their displacement affects the localization 
of the centromere chromatin proteins hMis12, hSgo1, and CPC 
(Fig. 2) after prophase.
HP1- and HP1- are required for 
chromatid cohesion during mitosis  
in human cells
In an effort to obtain direct evidence indicating that the altered 
localization of HP1 is critical to cohesion defects caused by 
Vpr, the effects of down-regulating HP1- and HP1- on cen-
tromere cohesion were investigated. Endogenous expression of 
HP1- or HP1- was knocked down using RNAi, and specific 
knockdown  was  confirmed  by  immunoblotting  (Fig.  S3  B).   
RNAi-treated cells were arrested by nocodazole, and then   
Giemsa-stained chromosome spreads were examined (Fig. 4 A).   
Note  that  chromosomes  from  HP1-  and  HP1-  (HP1-) 
RNAi cells appear swollen, with indistinct primary constrictions 
(Fig. 4 A), consistent with the morphological changes reported 
in hRad21-depleted cells (Toyoda and Yanagida, 2006). After 
transfection with HP1- and HP1- siRNA, PCS was induced 
in 10.7 and 4.2% of cells (Fig. 4 B), respectively. When both 
HP1- and HP1- were knocked down (HP1- RNAi), PCS 
occurred more frequently (in 19.8% of the spreads examined).
To  provide  further  evidence  that  HP1-  depletion  is 
linked directly to cohesin loss, we monitored the expression 
of  exogenous  myc8-tagged  hRad21.  HeLa  cells  were  trans-
fected with a plasmid encoding myc8 epitope–tagged hRad21 
(phRad21-myc8) with or without HP1- RNAi. Subsequently, 
we examined the expression of hRad21-myc8 by detecting the 
myc tag (see Materials and methods). Approximately 70% of 
cells  treated  with  control  siRNA  were  positive  for  hRad21-
myc8 (myc positive) within the pericentromeres (Fig. 4 C). In 
contrast, introduction of HP1- RNAi reduced the number of 
myc-positive cells to 30% (Fig. 4 C). Of note, PCS was observed 
in myc-negative cells (Fig. 4 D, right), clearly indicating that 
the down-regulation of HP1- induced cohesin defects that 
correlated with PCS. Our data support the idea that dissociation 
of HP1 from the heterochromatin is involved in Vpr-induced 
PCS. To further characterize Vpr-induced PCS, we transfected 
cells with hSgo1 RNAi and compared the phenotypic changes 
in  chromosome  spreads.  Down-regulation  of  hSgo1  protein 
was confirmed by immunoblotting (Fig. S3 A). Representative   
chromosome  spreads  prepared  from  Vpr-expressing  cells  or 
HP1- RNAi cells are shown in Fig. 4 E, and summarized 
results are also shown (Fig. 4, F and G). The effects of hSgo1 
RNAi on the loss of cohesin caused by the down-regulation 
of  HP1-  were  monitored  using  phRad21-myc8.  Approxi-
mately 30% of the cells were myc negative with control RNAi, 
and the numbers of myc-negative cells were dramatically in-
creased upon transfection with HP1- RNAi (Fig. 4, H and I). 
and HP1- (Fig. S2 E). In striking contrast, no apparent de-
crease in HP1- was detected (Fig. 3 A, middle row). Time 
course analysis of HP1- and hRad21 proteins revealed that 
HP1- from the isolated chromatin (Remboutsika et al., 1999) 
was undetectable within 48 h of the induction of Vpr expression 
(Fig. 3 B, top). The hRad21 levels from the chromatin isolated 
using a reported protocol (Todorov et al., 1995) also decreased 
over a 72-h period. In addition, the total amount of each protein 
in whole-cell extracts remained unchanged when Vpr was ex-
pressed (Fig. 3 B), suggesting that Vpr alters their subcellular 
localization without modulating their overall expression. Next,   
we characterized the chromatin-associated HP1- levels immuno-
histochemically  and  found  that  HP1-  became  undetectable   
under Vpr expression within 48 h in both mitotic and interphase 
cells (Fig. 3 C, top right). In contrast, it was clearly detected 
in control cells (Fig. 3 C, top left). Notably, chromatin-associated   
HP1- loss was observed in most of the Vpr-expressing interphase 
population  (Fig.  S2  E).  However,  the  chromatin-associated 
hRad21 loss was not major in regularly sized nuclei but was 
observed significantly in large nuclear cells (Fig. S2 B). These 
observations support the idea that a defect in HP1- precedes 
the alteration in hRad21.
To  identify  which  subtypes  of  HP1  proteins  were  af-
fected for the chromosome localization by Vpr, we investigated 
the localization of HP1 during mitosis immunohistochemically 
(Fig. 3 D). In control cells, HP1- localized to pericentromere 
regions and the inner centromere, consistent with a previous 
study (Kiyomitsu et al., 2010). HP1- localized to the chromo-
some arm, and HP1- localized to both the chromosome arm 
and centromeric regions (Fig. 3 D, left). Morphological analy-
sis of chromosome spreads from Vpr-expressing cells detected 
PCS in those lacking a centromeric HP1- or HP1- signal but 
not those lacking a HP1- signal (Fig. 3 D, right). CENP-H, 
a component of the inner kinetochore, was unaffected in Vpr- 
expressing cells (Fig. 3 D, right). These data suggest that HP1- is 
the HP1 subtype that is most strongly influenced by Vpr expres-
sion during mitosis.
HP1- and HP1- physically interact with hMis12, a kineto-
chore protein essential for chromosome segregation (Goshima   
et al., 2003; Obuse et al., 2004). Thus, hMis12 targeting in Vpr-
expressing cells was analyzed. Immunohistochemical analysis 
revealed that hMis12 was undetectable at mitotic kinetochores 
in Vpr-expressing cells. (Fig. 3 E), whereas the centromere-
specific histone H3 variant CENP-A was unaffected (Fig. 3 E). 
Simultaneous morphological analysis of chromosome spreads 
detected PCS in spreads that lacked hMis12 signals (Fig. 3 F, 
bottom). In addition, centromere proteins detected by an anti-
centromere antibody (ACA) that primarily binds to CENP-B 
were also unaffected by Vpr, similar to CENP-A and CENP-H   
(Fig. 3 H, right). We then characterized hMis12 localization 
during mitosis. In Vpr-expressing cells, hMis12 and CENP-A 
signals were both detectable at prophase (Fig. 3 G, top right). 
However, the hMis12 signal became nearly undetectable at pro-
metaphase (Fig. 3 G, bottom right). CENP-A was detected in 
the same specimens on separated sister chromatids (Fig. 3 G,   
bottom right inset). To obtain more robust data, the relative   
signal intensities of hMis12 and CENP-A were measured in >400 727 HP1 in mitotic centromere cohesion • Shimura et al.
Figure 4.  Loss of cohesin from the mitotic centromere by HP1- RNAi. (A) Giemsa­stained chromosomes from HeLa cells transfected with control (Cont), 
HP1­, HP1­, or combined HP1­ + HP1­ (HP1­) siRNA (48 h). (B) PCS frequencies. (C) Frequency of hRad21­myc8–positive cells among HH2B­EGFP–
positive cells transfected with control or HP1­ siRNA. (D) Control or HP1­ siRNA–transfected HeLa cells were cotransfected with hRad21­myc8 and 
histone H2B­EGFP (HH2B­EGFP). Chromosome spreads were stained for c­myc (red) and EGFP (green). Similar results were obtained in three independent 
experiments. (E) Giemsa­stained chromosome spreads from cells transfected with no RNA (control) or with hSgo1 siRNA (48 h). Vpr cells + DOX (top), 
MIT­23 cells + DOX (top middle), HeLa cells and control RNAi (bottom middle), and HeLa cells and HP1­ RNAi (bottom) are shown. (F) PCS frequencies 
in cells transfected with hSgo1 or control siRNA with or without Vpr expression. (G) PCS frequency in HeLa and HT1080 cells transfected with hSgo1 
or control siRNA with or without HP1­ RNAi. (H and I) Cells were transfected with control or hSgo1 siRNA with or without HP1­ RNAi followed by 
hRad21­myc8 transfection (48 h). (H) Chromosome spreads stained for c­myc (red) and EGFP (green). (I) Frequency of myc­negative cells among HH2B­
EGFP–positive cells. (H and I) Similar results were obtained in two independent experiments, and representative data are shown. (B, C, F, and G) Values 
represent the mean ± SD of three independent experiments. Bars: (A and E) 5 µm; (D and H) 10 µm.JCB • VOLUME 194 • NUMBER 5 • 2011   728
hSgo1 RNAi increased PCS under any of the tested conditions   
(Fig. 4 G) and produced a remarkable increase in the myc- 
negative cell population (Fig. 4, H and I), suggesting that hSgo1 
acts downstream of HP1- in the maintenance of centromeric 
cohesin  during  mitosis.  These  observations  were  similar  to 
those for Vpr-induced PCS (Fig. 4 F), lending support to the 
notion  that  Vpr-induced  PCS  depends  on  the  disruption  of   
HP1- function.
Chromatin recruitment of p300 by Vpr and 
displacement of HP1 from chromatin
Given that Vpr interacts directly with p300/HAT (Kino et al., 
2002),  a  HAT-regulating  transcription  (Boyes  et  al.,  1998; 
Caron et al., 2003), and that HP1- binds chromatin via histone 
H3 methylated at lysine 9 (H3K9; Jenuwein and Allis, 2001), 
we tested whether Vpr alters HP1- localization by modify-
ing the properties of this histone. First, we attempted to detect 
the acetylated form of H3K9 in condensed chromosomes, as 
Vpr-induced cohesin defects were specifically induced during   
mitosis. H3K9 associated with condensed chromosomes pre-
pared from Vpr-expressing cells was highly acetylated (Fig. 5 A,   
bottom middle). Note that acetylated H3K9 was detected at 
sites of primary chromosome constriction (Fig. 5 B, bottom). 
In  contrast,  less  acetylated  H3K9  was  detected  at  primary 
constriction sites in control cells (Fig. 5 B, top). Conversely, 
dimethylation on  H3K9 decreased  on  mitotic  chromosomes 
from Vpr-expressing cells (Fig. S5 A, bottom). Next, we ex-
amined p300 localization upon Vpr induction. Interestingly, we   
detected p300 in the condensed chromosomes of Vpr-expressing   
cells (Fig. 5 C, bottom). In marked contrast, p300 signals were 
not detected in control cells (Fig. 5 C, top). Furthermore, in-
creased levels of chromatin-associated p300 were detected in 
interphase and mitotic Vpr-expressing cells (Fig. 5 D, bottom 
insets), whereas no signal was detected in control mitotic cells 
(Fig. 5 D, top). A detailed analysis of condensed chromosomes 
showed that the Vpr signal was localized to the chromosome 
arms and enriched at the primary constriction of chromosomes 
(Fig. 5 E). Moreover, simultaneous staining showed that p300 
and  Vpr  colocalized  on  the  chromosome  (Fig.  5  F,  right). 
Costaining with CENP-A or CENP-H showed that Vpr and 
p300 localized to the centromere and arm region (Fig. 5, G and H). 
These data suggest that Vpr actively mobilizes p300 to a range 
of chromatin regions including the centromeres, resulting in 
the displacement of HP1- and PCS.
Figure 5.  Forced association of p300 with chromatin in Vpr-expressing 
cells. Chromosome spreads were prepared from DOX­treated cells at 48 h.   
Vpr  (),  Vpr  cells;  Vpr  (+),  MIT­23  cells.  (A)  Histone  H3  lysine  9  is 
strongly acetylated in the chromosomes, including centromeric regions. 
Chromosome spreads were immunostained with antiacetylated H3K9 anti­
body. (B) Typical centromere regions shown at a higher magnification. 
H3K9 was highly acetylated along the whole chromosome, including the 
centromere region, in Vpr­expressing cells (arrowheads). However, only 
a weak signal was detected at the primary constrictions of the chromo­
somes in control cells (arrows). (C) Chromosome spreads stained for p300.   
(D) Preextracted cells stained for p300. Arrows, cells undergoing mitosis. 
Insets, mitotic cells expressing Vpr. Vpr cells + DOX (top) and MIT­23 
cells + DOX (48 h; bottom) are shown. (E) Chromosome spreads stained 
for Vpr. (F) Chromosome spreads from DOX­treated MIT­23 cells stained 
for Vpr and p300. Arrows, signals at the centromere. Two pairs of sister 
chromatids are shown. (G and H) Chromosome spreads stained for CENP­
A and Vpr (G) and CENP­H and p300 (H). Similar results were obtained in 
three independent experiments. Bars: (C and E–H) 5 µm; (D) 10 µm.
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was partially inhibited by anacardic acid (AA), a p300/HAT in-
hibitor (Fig. S5 B), indicating that p300/HAT was present in the 
immunoprecipitate, although we cannot exclude a possibility of 
other HAT contamination in the Vpr immunoprecipitate.
Intriguingly, a Western blot analysis revealed that p300 
RNAi restored chromatin retention of HP1- in cells express-
ing Vpr  (Fig.  6  D).  Immunohistochemical  analysis  revealed 
p300/HAT is required for Vpr-induced 
displacement of HP1- and PCS
To demonstrate the involvement of p300/HAT in Vpr-induced 
PCS, we further characterized p300 in Vpr-expressing cells.   
After first confirming that Vpr associated with p300 (Fig. 6 A), 
we subsequently showed that a Vpr immunoprecipitate demon-
strated HAT activity against H3K9 (Fig. 6, B and C). This activity 
Figure 6.  p300 is required for Vpr-induced PCS. (A) Expression of p300 or Vpr in immunoprecipitates (IP) measured using anti­Vpr and anti­p300 anti­
bodies and control (Cont) IgG. Cells were transfected with pCMV­Vpr (Vpr) or control vector (Vec). (B) Vpr immunocomplexes exhibit HAT. 293T cells were 
transfected with Flag­EGFP, Flag­Vpr, and Flag­p300 (positive control), and HAT activity was measured. Flag­immunoprecipitated Flag­Vpr showed higher 
HAT activity than did Flag­EGFP, control IgG, IP­Flag­EGFP, or Flag­Vpr. IP­Flag­p300 reached maximal levels 2 h before measurement, indicating that 
actual p300 HAT activity may be higher than the measured value. Results shown are representative of two independent experiments. (C) HAT activity in Vpr­
expressing cells. HAT activity targeting histone H3K9 in Flag­EGFP or Flag­Vpr immunoprecipitates was examined using histone H3 (HH3) as a substrate.   
(D) Expression of HP1­ in the isolated chromatin of Vpr­expressing MIT­23 cells (+DOX, 48 h) transfected with control or p300 siRNA. (left) Immuno­
blotting of the indicated proteins. ­Tubulin (Tub), whole­cell lysate loading control; HH3, isolated chromatin loading control. (right) Quantification of the 
HP1­ intensities shown in the immunoblot. RNAi of p300 in Vpr­expressing cells (lane 3) reversed the amount of chromatin­bound HP1­ compared with 
control RNAi (lane 2) with statistical significance (*, P = 0.046). Values represent the mean ± SD of three independent experiments. (E) Immunostaining of 
chromatin­bound HP1­, p300, and Vpr. Typical micrographs are shown. The levels of chromatin­bound HP1­ in Vpr­expressing cells were restored when 
p300 was down­regulated (right panels). Vpr (), DOX­treated Vpr cells at 48 h; Vpr (+), DOX­treated MIT­23 cells at 48 h. Bar, 10 µm. (F) PCS frequen­
cies in cells treated with p300 siRNA or AA (7.5 µM in DMSO) in the presence of Vpr expression. Values represent the mean ± SD of three independent 
experiments. *, P = 0.0009 for p300 RNAi and P = 0.0088 for AA versus control RNAi in DOX­induced MIT­23 cells.JCB • VOLUME 194 • NUMBER 5 • 2011   730
chromatin-bound hRad21 was likely diminished second, sug-
gesting that HP1- is a key factor in Vpr-induced PCS and that 
HP1  is  essential  for  centromere  cohesion  during  mitosis  in   
human cells. Vpr displaced HP1, whose RNAi-mediated down-
regulation induced PCS concomitant with the displacement of 
hRad21, consistent with a previous finding for hSgo1 (Yamagishi 
et al., 2008). Although the functional link between heterochro-
matin and centromere cohesion in humans remains controver-
sial,  Yamagishi  et  al.  (2008)  and  our  current  observations 
suggest a strong functional connection between heterochroma-
tin and centromere cohesion. We further suggest that patho-
genic microorganisms can epigenetically impair the function   
of centromeric heterochromatin.
The present data support the idea that HP1- plays a   
major role in centromere cohesion during mitosis and that cen-
tromere cohesion may be maintained by a network involving 
HP1- and HP1- (Obuse et al., 2004). Consistent with our 
data,  immunohistochemical  analyses  of  metaphase  spreads 
have shown that HP1- associates with centromeres during 
mitosis (Minc et al., 1999; Hayakawa et al., 2003; Yamagishi 
et al., 2008; Kiyomitsu et al., 2010). On the other hand, all sub-
types of HP1 are released from chromatin during M phase as a 
result of histone H3 phosphorylation, which is mediated by 
AurB kinase (Fischle et al., 2005; Hirota et al., 2005). These 
findings suggest that most HP1 proteins are released during 
mitosis but that a small amount of HP1- remains in the cen-
tromere region with hSgo1 to protect cohesin from removal 
until the onset of anaphase.
Notably,  our  observation  suggests  that  the  HP1-– 
mediated regulation of cohesion is especially important during 
mitosis. Accordingly, AurB, INCENP, hSgo1, and human inner 
kinetochore  protein  (hMis12)  were  initially  observed  during 
prophase at the centromere, even in cells in which HP1- was 
down-regulated by Vpr, but these proteins were displaced when 
the  cells  entered  prometaphase.  Given  that  the  depletion  of 
AurB or INCENP by RNAi resulted in altered hSgo1 localiza-
tion during mitosis, whereas hSgo1 RNAi did not significantly 
affect AurB or INCENP localization to the inner centromeres 
(Kawashima et al., 2007; Pouwels et al., 2007), the effect of the 
loss of hSgo1 on Vpr expression may be mediated by the loss of 
the CPC from the inner centromere. These observations further 
suggest that cohesion is maintained by a network involving 
HP1- and HP1-, especially during mitosis.
In Vpr-induced PCS, p300 might be responsible for the 
displacement of HP1- from chromatin. In particular, the inter-
action of Vpr and p300 is essential for the displacement of HP1- 
from chromatin, as mutant Vpr with a defective p300-binding 
leucine/arginine-rich  (LR)  domain  (LR  mutant;  Kino  et  al., 
2002) caused no apparent induction of PCS (Fig. S5 E). In our 
study,  the  artificial  expression  of  p300  by  itself  resulted  in   
neither the localization of p300 at insoluble nuclei nor PCS. In 
control cells, no association with p300 was detected in chromo-
some spreads, although an appropriate amount of p300 is   
essential for proper chromosome segregation (Ha et al., 2009). 
These data suggest that the stabilized association of p300 with 
chromatin as seen in Vpr-expressing cells is unusual. Interest-
ingly, the abnormal association of p300 with chromatin through 
that p300 RNAi restored the chromatin levels of HP1- in   
Vpr-expressing cells (Figs. 6 E and S4, A [right] and B). RNAi 
depletion of p300 specifically down-regulated the p300 levels   
(Figs. 6 E, S3 A, and S4 A [left]). These data strongly suggest   
that  p300  was  responsible  for  the  displacement  of  HP1-  
from chromatin.
To  provide  more  convincing  evidence  that  HAT/p300 
contributes to Vpr-induced PCS, we performed additional ex-
periments. First, we showed that AA reduced the rate of PCS 
(Fig. 6 F). Importantly, we confirmed that AA did not inhibit the 
chromatin recruitment of p300 in Vpr-expressing cells (Fig. S5, 
C and D). Second, we demonstrated that the down-regulation of 
p300 using RNAi also reduced the frequency of Vpr-induced 
PCS (Fig. 6 F). Moreover, although forced expression of p300 
cDNA increased the frequency of Vpr-induced PCS (Fig. 7,   
A–C), neither PCS nor an increase in the level of chromatin- 
associated p300 was observed in the absence of Vpr expression 
(Figs. 7 [C–E] and S4). Forced expression of p300 cDNA lack-
ing a catalytic domain (amino acids 1,472–1,522; HAT-p300; 
Fig. 7 A) did not increase the frequency of Vpr-induced PCS 
(Fig. 7 C). We confirmed this finding through back transfection 
with an expression plasmid encoding an RNAi-resistant wt p300 
cDNA (Fig. 7 F). Transfection with this plasmid increased the 
rate of Vpr-induced PCS, reversing the effects of p300 RNAi 
(Fig. 7, F–H). In contrast, a second plasmid encoding an RNAi-
resistant form of HAT-p300 did not affect the rate of PCS   
(P < 0.01; Fig. 7 H). We confirmed that both plasmids fostered 
similar levels of p300 expression (Fig. 7 G), with p300 be-
ing associated with chromatin in Vpr-expressing cells (Fig. 7,   
D and E). These data led us to conclude that the catalytic activity 
of p300 is crucial to Vpr-induced PCS and that Vpr aberrantly 
recruits p300 to chromatin, causing HP1- to be displaced.
Discussion
HIV-1 infection has come to be considered a chronic infection 
since the introduction of antiretroviral therapy, which can be 
used to control HIV-1 production for extended periods, thereby 
improving patient prognosis (Mermin et al., 2008). However, 
integrated HIV-1 proviral copies cannot be eradicated from the 
host genome, and small numbers of progeny virions are still 
produced during therapy (Corbeau and Reynes, 2011). There-
fore, it is essential to know how the virus influences host cells. 
Previously,  we  detected  10  ng/ml  Vpr  in  HIV-1–infected   
patient sera (Hoshino et al., 2007), and we showed that Vpr- 
expressing cells exhibited hyperploidy and aneuploidy (Shimura 
et al., 1999). We also found PCS, a hallmark of aneuploidy 
(Thompson et al., 1993; Kajii et al., 2001), in HIV-1–infected 
individuals  (Shimura  et  al.,  2005).  In  this  study,  we  found 
that  the  vpr  gene  is  responsible  for  HIV-1–associated  PCS.   
Therefore,  we  focused  on  the  molecular  mechanisms  of   
Vpr-induced PCS.
Vpr-expressing  cells  induce  PCS,  which  is  associated 
with reduced levels of cohesin, hSgo1, and HP1 and of the re-
lated  proteins  hMis12,  AurB,  and  INCENP  at  chromatin. 
Among these proteins, immunofluorescence analyses indicated 
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to cooperate with p300 and to enhance the transcriptional ac-
tivity of LTRs by up-regulating NF-B (Felzien et al., 1998). 
Our results suggest that the enhanced LTR transcription may 
be mediated by Vpr-induced p300 retention as a result of bind-
ing to chromatin. Host cells suppress HIV-1 LTR activity by 
histone deacetylation, as HIV-1 enters latency through histone 
deacetylase (HDAC) recruitment to HIV-1 LTRs (Williams   
et al., 2006), and HDAC inhibitors increase HIV-1 expression 
(Matalon et al., 2011). HAT activity caused by the p300–Vpr 
Vpr was found both in interphase and M phase. The Vpr- 
mediated binding of p300 to chromatin could be essential for 
the displacement of HP1-. However, the molecules required 
for the chromatin recruitment of Vpr remain to be clarified.
A variety of microorganisms expresses proteins that tar-
get p300/HAT and modulate its activity (Hottiger and Nabel, 
2000; Caron et al., 2003). p300 functions as a critical regulator 
of transcription from integrated HIV-1 long terminal repeats 
(LTRs; Marzio et al., 1998). Vpr, meanwhile, has been shown 
Figure 7.  p300 HAT activity is required for Vpr-induced PCS. (A) HAT activity in Flag­p300– or Flag­p300HAT–expressing cells. The acetyltransferase 
deletion mutant p300HAT (1,472–1,522) displayed no activity in a HAT activity assay. Mean values are shown. ND, none detected. Results shown are 
representative of two independent experiments. (B) A schematized experimental procedure of C. (C) PCS frequency in Vpr­expressing and ­nonexpressing 
cells transfected with pFlag­p300 or pFlag­p300HAT (48 h). Values represent the mean ± SD for independent experiments (n = 2–8). Cont, control.   
(D) The chromatin loading of Flag­p300 or Flag­p300HAT protein in cells expressing Vpr. Cells were preextracted with PBS containing Triton X­100 
and stained for Flag M2 epitope and DNA. Levels of chromatin­bound Flag­p300 or Flag­p300HAT were comparable in Vpr­expressing cells. Non– 
Vpr­expressing cells contained no chromatin­bound Flag­p300 or Flag­p300HAT. Bar, 10 µm. (E) Quantification of Flag­p300/Flag­p300HAT signal inten­
sities in D. Results shown are representative of two independent experiments. Arb., arbitrary. (F, top) A schematized experimental procedure of G and H. Gray 
underlined letters represent mutation sites in the RNAi­resistant wt and p300HAT cDNA plasmids. (bottom) Mutations introduced to prepare RNAi­resistant 
Flag­p300wt (pFlag­p300wtR) and RNAi­resistant p300HAT (p300HAT­R). (G) Western blotting to verify that the expression of pFlag­p300wtR was not 
affected by p300RNAi. Arrowhead, Flag­EGFP; dot, nonspecific band. Tub, ­tubulin. (H) PCS frequency in Vpr­expressing cells transfected with pFlag­
p300wtR or p300HAT­R (48 h) and plasmids carrying RNAi­resistant Flag­p300wt and RNAi­resistant p300HAT. Values represent the mean ± SD of three 
independent experiments. PCS frequency was significantly lower in cells expressing p300HAT­R than in those expressing p300wtR. *, P = 0.0003.JCB • VOLUME 194 • NUMBER 5 • 2011   732
DNA plasmids and transfection
A plasmid encoding hRad21­myc8 (phRad21­myc8) was constructed by 
inserting the entire coding region of hRad21 and eight tandem copies of 
the myc antigen in­frame into pcDNA3.1/V5His6 (Invitrogen), as previ­
ously described (Toyoda and Yanagida, 2006). The plasmid pH2BGFP 
encodes the chimeric protein histone H2B­EGFP (Kanda et al., 1998). The 
phRad21­myc8 and pH2BGFP plasmids were cotransfected into HeLa cells 
at a 5:1 ratio using the Effectene Transfection kit (QIAGEN). A DNA plas­
mid encoding Flag­tagged wt p300 (pFlag­p300wt) was generated using 
pFlag­p300HAT, together with Flag and p300wt, as previously described 
(Boyes et al., 1998). The 5 fragment of pFlag­p300HAT was excised   
using  SnaBI  and  XbaI,  recovered,  and  ligated  into  the  corresponding 
p300wt sites. To generate DNA expression plasmids encoding an siRNA­
resistant form of p300, a 2.5­kb SpeI fragment (nucleotides 420–2,870 
from the initiation codon) was first subcloned into a pBluescript KS II(+) 
vector (Agilent Technologies). An oligonucleotide cassette (5­CCAGATGA­
GCATGGCCCAGCCCCCTATTGTACCCCGGCA[GACTCCACCATTGC­
AA  CATCA]TGGACAGTTGGCTCAACCTGGAGCT­3; brackets identify the 
siRNA  target  site,  whereas  underlined  nucleotides  are  mismatched  but   
encode the same amino acids) was inserted between the MscI and SacI 
sites of p300 cDNA. The sequence of the resulting construct was confirmed 
by sequencing, and the 2.5­kb SpeI fragment was then excised and in­
serted into the same sites in pFlag­p300wt and pFlag­p300HAT. The cor­
rect orientation of the inserted fragment and the presence of mismatched 
nucleotides were confirmed by restriction mapping and sequencing, respec­
tively. The primer used to confirm the presence of mismatched nucleotides 
was 5­CGGAGCCAAAGGGATATTTG­3, which is a reverse primer and 
adheres from nucleotide 2,333 of the p300 cDNA transcription initiation 
site.  A  DNA  plasmid  encoding  Flag­tagged  EGFP  was  constructed  by   
inserting  an  oligonucleotide  (5­AATTACCATGGACTACAAAGACGAT­
GACGACAAG­3) between the EcoRI and BamHI sites of pBOS2EGFP. 
Correct oligonucleotide insertion was confirmed by sequencing.
RNAi
siRNAs were used to block the expression of NIPBL, hSgo1, HP1­, HP1­,   
and p300. The siRNA sequences used are as follows: NIPBL, 5­GCUU­
UUGAAUCCUCUAGGATT­3  (Toyoda  and  Yanagida,  2006);  hSgo1, 
5­CAGUAGAACCUGCUCAGAA­3 (McGuinness et al., 2005); HP1­, 
5­CCUGAGAAAAACUUGGAUUTT­3; HP1­, 5­UAUUUCCUGAAGUG­
GAAGGTT­3  (Obuse  et  al.,  2004);  and  p300,  5­AACCCCUCCU­
CUUCAGCACCA­3 (Debes et al., 2002). A double­stranded RNA with 
the sequence 5­UAAGGCUAUGAAGAGAUAC­3 (siCONTROL nontar­
geting siRNA #2; Thermo Fisher Scientific) was used as a control. RNAi 
procedures were performed according to the instructions included in the 
Oligofectamine kit (Invitrogen) for HeLa cells and the Nucleofector kit T   
(Lonza)  or  GenePORTER  kit  (Genlantis)  for  HT1080­based  cell  lines.   
In single transfections, siRNA was used at a concentration of 200 nM; 
in combined RNAi treatments, each siRNA was used at a concentration   
of 100 nM.
FACS analysis
A flow cytometer (FACSCalibur; BD) was used in cell cycle analyses, as 
previously described (Shimura et al., 1999). In brief, cells fixed in 70% 
ethanol at 20°C for at least 1 h were treated with 100 µg/ml RNase 
(Sigma­Aldrich) and stained with 5 µg/ml propidium iodide (Sigma­ 
Aldrich) to allow visualization of the DNA.
Cell extraction and immunoblotting
Chromatin was isolated for HP1 immunoblotting using a combination of 
previously described methods (Remboutsika et al., 1999). In brief, cells 
were washed twice in ice­cold PBS and then resuspended in buffer N   
(15 mM Tris­HCl, pH 7.5, 60 mM KCl, 15 mM NaCl, 5 mM MgCl2,   
1  mM  CaCl2,  1  mM  dithiothreitol,  2  mM  sodium  vanadate,  250  mM   
sucrose, protease inhibitor cocktail [Sigma­Aldrich], and 1 mM PMSF). 
An equal volume of buffer N containing 0.6% NP­40 was then added 
to the resuspended cells, and the resulting suspension was mixed gently 
and incubated on ice for 5 min. Nuclei were pelleted by centrifugation 
at 2,000 g for 5 min at 4°C. After three washes in buffer N, they were 
lysed in 10 mM Pipes buffer, pH 6.5, containing 10 mM EDTA, protease 
inhibitor cocktail, and 1 mM PMSF. The resulting chromatin pellets were 
washed once in Pipes buffer and resuspended in SDS­PAGE loading buffer 
after centrifugation at 6,000 g for 10 min at 4°C. Equivalent samples (in 
terms of initial DNA and the final protein) from the supernatant fractions 
were subjected to 10–15% SDS­PAGE. A control (­tubulin, PSTAIRE, HH3, 
or Coomassie brilliant blue stain) was used to confirm equivalent loadings 
complex at chromatin may contribute to viral transcription by 
overcoming host cell HDACs. Moreover, Vpr-mediated p300 
binding to chromatin may provide an advantage for viral inte-
gration. It is notable that integration of the HIV-1 genome into 
that of the host cell occurs preferentially near transcriptionally 
active genes (Brady et al., 2009). The Vpr-induced association 
of p300 with chromatin may influence transcriptional activity 
and hence favor viral integration. Cereseto et al. (2005) re-
ported that the HIV-1 protein integrase, which catalyzes HIV-1 
integration (Chow et al., 1992), bound p300 directly and that 
the acetylated integrase showed increased affinity for DNA 
and stimulated viral integration. The stabilized association of 
p300 with chromatin caused by Vpr may facilitate the active 
recruitment of integrase to chromatin, thereby favoring effi-
cient integration of the viral genome. We anticipate that the 
Vpr-induced stable association of p300 with chromatin may 
favor active viral production by affecting the functions of other 
nuclear proteins. It was recently proposed that p300/HAT an-
tagonists could be useful in anti-AIDS therapies (Mantelingu 
et al., 2007). Blocking the molecular interactions of Vpr and 
p300 could inhibit the recruitment of p300/HAT to chromatin 
and thus reduce viral replication. It could also reduce the ge-
nomic instability associated with PCS.
This is the first study to reveal centromere cohesion impair-
ment via the epigenetic disruption of heterochromatin by a viral 
pathogen. The use of Vpr expression, RNAi, and specific inhibi-
tors, in combination with appropriate functional assessments, re-
vealed a new specific mechanism of chromosome cohesion. Vpr 
expression could therefore be considered a useful system for fur-
ther study of the complex regulation of chromatin dynamics.
Materials and methods
Viruses and infection
VSV­G–pseudotyped viruses were produced by cotransfecting 293T cells 
with the infectious HIV­1 proviral clones pNL­Luc­E
 (wt; Connor et al., 
1995), pNL­Luc­E
F
 (Vif deficient; Kinomoto et al., 2007), pNL­Luc­E
R
 
(Vpr deficient; Connor et al., 1995), and pNL­Luc­E
U
 (Vpu deficient; 
Iwabu et al., 2009) using the VSV­G expression vector pHIT/G (Fouchier 
et al., 1997) and FuGENE 6 transfection reagent (Roche). Levels of p24 
antigen in culture supernatants were measured using an HIV­1 p24 antigen 
capture ELISA kit (ZeptoMetrix). PBLs were donated by healthy volunteers 
approved by the Institutional Ethics Committee of the National Center for 
Global Health and Medicine. 1.5 × 10
6 PBLs were infected with 2 ng/ml 
p24 antigen from wt or mutant virus (multiplicity of infection 0.007) to   
obtain a similar PCS frequency to that typically found in HIV­1 patients 
(Shimura et al., 2005) in the presence of 2% phytohemagglutinin­M form 
(Invitrogen). 82 h later, infected cells were analyzed for luciferase activity 
using PicaGene (Toyo Ink) and for overall protein content using a bicincho­
ninic acid assay (Thermo Fisher Scientific). Luciferase counts were normal­
ized using the total protein in infected cells.
Cells
The cell lines used in this study were HT1080, a human fibrosarcoma cell 
line  (JCR  B9113;  Health  Science  Research  Resource  Bank);  MIT­23,  a 
DOX­inducible Vpr­expressing cell line (Shimura et al., 1999); Vpr mock­
transfected cells derived from HT1080 cells; 293T cells; and HeLa cells. All 
cell lines were cultured in a humidified incubator in DME (Nissui) supple­
mented with 10% FBS at 37°C and in a 5% CO2 atmosphere. To induce 
Vpr expression in MIT­23 cells, 3 µg/ml DOX (Sigma­Aldrich) was added 
to the culture medium. Vpr protein expression was detected within 24 h of 
DOX treatment. More than 95% of the DOX­treated cells expressed Vpr, as 
confirmed by immunostaining. At 48 h after treatment, the mitotic index in 
DOX­induced MIT­23 cells had increased by 8%, whereas it had in­
creased by <2% in noninduced Vpr control cells.733 HP1 in mitotic centromere cohesion • Shimura et al.
for  5  min  in  a  cytocentrifuge  (Thermo  Fisher  Scientific).  The  margins   
of  the  resulting  preparations  were  marked  using  a  PAP  Pen  (Invitro­
gen), and the slides were then washed for at least 10 min in buffer A   
(10 mM Tris­HCl, pH 8.0, 120 mM NaCl, 0.5 mM EDTA, and 0.1% Triton   
X­100). Next, they were incubated for 1 h at RT in a humid chamber with 
primary antibodies against CENP­A (1:100; Abcam); ACA (1:20; MBL 
International Corp.); CENP­H (1:100; rabbit pAb; provided by K. Yoda); 
hRad21 (1:200; provided by F. Ishikawa, Kyoto University, Kyoto, Japan); 
hSgo1 (1:1,000); hMis12 (1:200); HP1­, HP1­, or HP1­ (1:500; mAb 
3584, 3448, or 3450; Millipore); p300 (1:500; mAb; Millipore); Vpr 
(1:400; rabbit pAb; TT144­1; Shimura et al., 1999); acetylated H3K9 
(1:250; rabbit pAb; Cell Signaling Technology); and c­Myc (1:50; 9E10; 
Santa Cruz Biotechnology, Inc.). Primary antibodies were diluted in buffer A   
containing 10% goat serum. In the double staining of hRad21­myc and 
histone H2B­GFP, preparations were first stained for c­Myc for 30 min be­
fore anti­GFP antibody (1:50,000; MBL International Corp.) was applied 
for a further 30 min. After three washes in buffer A (once for 1 min and 
twice for 5 min), slides were next incubated with the secondary antibody 
Alexa  Fluor  546–conjugated  anti–mouse  IgG  (1:1,000;  Invitrogen)  or 
biotinylated anti–human IgG (1:500; Dako) and were then incubated for   
30 min at RT in a humid chamber with streptavidin­FITC (1:500; Invitrogen), 
Alexa  Fluor  546–conjugated  anti–rabbit  IgG  (1:1,000;  Invitrogen),   
Alexa Fluor 488–conjugated anti–rabbit IgG (1:400), or Alexa Fluor 488– 
conjugated anti–mouse IgG (1:400). The preparations were then washed 
three times (once for 1 min and twice for 5 min) and fixed in 4% PFA in 
buffer A for 15 min at RT. After being washed in PBS containing 1 mM 
PBS­EGTA, slides were stained with DAPI or Hoechst 33342 to visualize 
DNA. They were finally washed in PBS­EGTA for 5 min and mounted in 
antifade mounting medium (Kirkegaard and Perry Laboratories) before 
subsequent immunofluorescence microscopic analysis (see Immunofluores­
cence microscopy section).
Immunoprecipitation and HAT assay
To capture immunocomplexes, Dynabeads (Invitrogen) preincubated with 
either a mouse mAb against Vpr (8D1; Nakai­Murakami et al., 2007) 
or an anti­p300 pAb (N­15; Santa Cruz Biotechnology, Inc.), as well as 
mouse IgG (Sigma­Aldrich) or rabbit IgG (Sigma­Aldrich), were added to 
1,000 µg cellular protein suspended in 250 µl lysis buffer. The resulting 
mixtures were incubated at 4°C overnight. The beads were then washed 
once with ice­cold buffer and boiled in sample buffer. The resulting   
immunocomplexes were analyzed using an anti­Vpr (8D1) mAb (1:1,000; 
Nakai­Murakami et al., 2007) or an anti­p300 pAb (1:100; N­15; input, 
10% of the protein used in immunoprecipitation; Santa Cruz Biotechnol­
ogy, Inc.). For HAT activity assays, Dynabeads coincubated with a mouse 
mAb against Flag (M2; Sigma­Aldrich) or a control mouse IgG were added 
to 1,000 µg cellular protein suspended in 250 µl lysis buffer, and the re­
sulting mixtures were incubated at 4°C overnight. The beads were washed 
with ice­cold buffer and then with 1× HAT assay buffer (HAT assay kit; 
Millipore) according to the manufacturer’s instructions. Next, a HAT assay 
cocktail containing 10 µg histone H3 (Millipore) and 100 µM acetyl­CoA 
(Sigma­Aldrich) was added to the beads, which were then incubated at 
30°C in a shaking incubator for 30 min. Acetylation of histone H3 was 
assessed by Western blotting, performed using an antiacetylated histone 
H3 antibody (1:1,000; Cell Signaling Technology).
HAT activity
293T cells were transfected with Flag­EGFP, Flag­Vpr, or Flag­p300 (posi­
tive control). To capture immunocomplexes, Dynabeads conjugated with 
anti­Flag (M2) antibody (Sigma­Aldrich) or a control IgG (mouse mAb) 
were added, and the resulting mixtures were incubated at 4°C overnight. 
HAT activity was measured using a colorimetric assay (MBL International 
Corp.) according to the manufacturer’s instructions. In brief, beads were 
washed with ice­cold TBS buffer. They were then mixed with a HAT sub­
strate and incubated at 37°C in a shaking incubator for 3–6 h.
Statistical analysis
Statistical  analyses  were  performed  using  a  two­tailed  unpaired  t  test.   
P < 0.05 was considered statistically significant.
Online supplemental material
Fig. S1 shows a PCS assay in two additional PBL donors, Vpr expression 
levels, and abnormal chromosome segregation in Vpr­expressing cells ac­
companying Videos 1–3. Fig. S2 shows the effects of Vpr expression on the 
interphase chromatin localization of hRad21 and HP1­ and an assessment 
of NIPBL in Vpr­induced PCS. Fig. S3 shows the specific down­regulation   
in each lane. Cellular extraction for cohesion analyses was performed 
as previously described (Todorov et al., 1995), with slight modifications.   
After washing in PBS and cytoskeleton (CSK) buffer (10 mM Pipes, pH 7.0,   
100 mM NaCl, 300 mM sucrose, and 3 mM MgCl2), cells were incubated 
for 5 min at RT in CSK extraction buffer (CSK buffer containing 0.5% Triton 
X­100, 0.5 mM PMSF, and protease inhibitor cocktail). Particulates were 
pelleted by centrifugation at 700 g for 5 min at 4°C. The resulting pellets   
were washed three times in CSK extraction buffer and lysed in radio­
immunoprecipitation assay buffer (50 mM Tris­HCl, pH 8.0, 150 mM NaCl, 
1% NP­40, 0.5% sodium deoxycholate, 0.1% SDS, and protease inhibitor 
cocktail) and were then sonicated on ice. Equivalent amounts of protein 
were subjected to 10–15% gradient SDS­PAGE. In immunoblot analysis, 
cell extracts were transferred to nitrocellulose membranes after SDS­PAGE. 
After blocking in 10% BSA (Sigma­Aldrich), membranes were incubated 
with antibodies against SMC1 or SMC3 (provided by K. Kimura, Tsukuba 
University, Tsukuba, Japan), HP1­ (Millipore), HP1­ or HP1­ (provided 
by T. Haraguchi and T. Hayakawa, Kobe Advanced Information and Com­
munications Technology Research Center; National Institute of Information 
and Communications Technology, Kobe, Japan), NIPBL/delangin (Toyoda 
and Yanagida, 2006), p300 (Millipore), hRad21 (Abcam), or ­tubulin 
(Millipore). The anti­Vpr antibody 8D1 (IgG2a) was raised by immuniza­
tion with a full­length Vpr peptide (Peptide Institute, Inc.; Nakai­Murakami 
et  al.,  2007).  Immune  complexes  were  detected  using  anti–rabbit  or   
–mouse IgG Fab fragments (GE Healthcare) conjugated to HRP. Bound anti­
body was visualized using a Western blot detection system (ECL Plus; GE 
Healthcare). The intensity of the scanned blots was measured on ImageJ 
software (National Institutes of Health).
Immunofluorescence microscopy
Immunofluorescence  staining  was  performed  as  previously  described 
(Shimura et al., 1999). In brief, cells were washed in PBS, fixed in 2% 
PFA in PBS for 10 min, permeabilized with 0.2% Triton X­100 in PBS for 
10 min, and blocked with 10% goat serum or 1% BSA in PBS. To remove 
soluble proteins while leaving chromatin­bound proteins intact, cells were 
incubated in PBS or CSK buffer containing 0.2% Triton X­100 and 1% 
BSA for 5 min on ice and were then fixed in 2% PFA in PBS for 10 min. 
Primary antibodies against hMis12 (1:1,000; Goshima et al., 2003), 
AurB (1:200; BD), INCENP (1:200; Bethyl Laboratories, Inc.), CENP­A 
(1:200; Abcam), CENP­H (1:200; provided by K. Yoda), hRad21 (1:50;   
Toyoda and Yanagida, 2006), hSgo1 (1:1,000; provided by Y. Watanabe, 
Tokyo University, Tokyo, Japan), HP1­ (1:100; D15; Santa Cruz Biotech­
nology, Inc.), p300 (1:100; rabbit pAb N­15; Santa Cruz Biotechnol­
ogy, Inc.), Vpr (1:400; mouse mAb 8D1), and Flag M2 (1:500; mouse 
mAb; Sigma­Aldrich) were then applied. Slides were mounted in antifade 
mounting medium (Kirkegaard and Perry Laboratories) and observed un­
der a microscope (BX50; Olympus) equipped with a Plan Apochromat 
objective lens with immersion oil (nd = 1.516 at 23°C; Olympus) and 
a  charge­coupled  device  camera  (Sensys;  Photometrics).  Images  were 
acquired using IPLab Spectrum software (Scanalytics, Inc.). TIFF images 
acquired using IPLab Spectrum were imported into Photoshop (Adobe). 
Signal intensities per unit area in TIFF images acquired using IPLab Spec­
trum were measured using ImageJ software. Over 100 sister kinetochores 
(for hMis12) or inner centromeres (for AurB and INCENP) at prophase 
and prometaphase were measured.
Preparation of chromosome spreads
Cells were treated with 0.1 µg/ml colcemid (Invitrogen) for 2 h or with   
0.1 µg/ml nocodazole (Sigma­Aldrich) for 4 h at 37°C. Rounded cells 
and cells in mitotic arrest were collected, washed in PBS, and incubated in 
75 mM KCl for 10 min at RT. Next, 10% (volume/volume) KCl in freshly 
prepared Carnoy’s solution (a 3:1 mixture of methanol and glacial acetic 
acid) was added to the cell suspensions, which were then mixed gently. The 
Carnoy’s solution was replaced three times. Drops of cell suspension were 
then spotted onto glass slides and air dried. To visualize chromosomes, 
the slides were stained for 5 min with 6% Giemsa (Merck) in phosphate   
buffer, pH 6.8. More than 300 chromosome spreads were examined in 
each experiment. A chromosome spread was considered PCS positive if 
more than three chromosomes lacked linkages between sister chromatids.
Immunofluorescence labeling of chromosome spreads
Immunofluorescence labeling of chromosome spreads was performed as 
previously described (Jeppesen et al., 1992; Vagnarelli and Earnshaw, 
2001), with slight modification. Round cells undergoing mitosis were col­
lected, washed in PBS, gently resuspended in 75 mM KCl, and incubated 
for 10 min at RT. They were transferred to slides through rotation at 600 rpm   JCB • VOLUME 194 • NUMBER 5 • 2011   734
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